Michael Wagner, M.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Adaptimmune
    Topic:
    Scientific advisory board
    Date added:
    12/20/2021
    Date updated:
    04/09/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Deciphera
    Topic:
    Scientific advisory board
    Date added:
    12/20/2021
    Date updated:
    04/09/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Epizyme
    Topic:
    Scientific advisory board
    Date added:
    12/20/2021
    Date updated:
    04/09/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Aadi
    Topic:
    Scientific advisory board
    Date added:
    04/09/2023
    Date updated:
    04/09/2023
Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes